Slides
Page 1
Trading Statement Q3 2026 — Dr Jean-Yves Parisot (CEO), Olaf Klinger (CFO) October 28, 2026
Page 2
— Agenda Overview 2 Dr Jean-Yves Parisot, CEO Olaf Klinger, CFO 1 Q3 2026 Review 2 Strategy & Transformation Update 3 2026 Outlook
Page 3
3 01 Q3 2026 Review
Page 4
— 1 Q3 organic sales growth of 5.3% exceeded expectations Supported by sustained business momentum and more favorable year-over-year comparables 2 Broad-based volume-led growth underscores strong execution and solid customer demand Food & Beverage continued to deliver market-leading growth, Pet Food and Care & Wellness returned to growth 3 Advancing portfolio actions and ONE SYM Transformation initiatives Strengthening portfolio quality, organizational effectiveness and customer competitiveness 4 Share buyback progressing 4.3 million shares repurchased and approximately €348 million deployed through end of September 5 Full-year outlook reaffirmed 4 Q3 2026 Highlights Q3 2026 REVIEW
Page 5
— 487 520 27 12 736 790 38 16 65 28 Q3 2026: Sales Performance with Broad-Based Growth Across Segments 5 Strong volume-driven organic sales growth and improving momentum across the portfolio Taste, Nutrition & Health in€m Scent & Care in€m Group in€m Q3 2026 REVIEW • Food & Beverage: Continued market-leading mid- single-digit organic sales growth, driven by double digit growth in Naturals, high-single-digit organic sales growth in Sweet and mid-single-digit organic sales growth in Savory; low-single-digit organic sales decline in Beverages against strong prior-year comparables. Performance reflects broad-based volume growth, technical differentiation and strong customer execution. • Pet Food: Returned to growth with low-single-digit organic sales growth, supported by positive volume- driven development in Palatability and Pet Nutrition; Pet Nutrition continued to be affected by price normalization • Organic sales growth of 5.3%, driven by volumes • Portfolio effect includes consolidation of Floral Concept and the divestment of Terpene Ingredients business¹ • Positive FX translation in Q3, including USD tailwind • Fragrance: Mid-single-digit organic sales growth; Consumer Fragrance continued strong performance with high-single-digit organic sales growth; Fine Fragrance returned to low-single-digit organic sales growth, supported by continued project vitality • Care & Wellness: Returned to low-single-digit organic sales growth with continued sequential improvement; double-digit organic sales growth in Advanced Actives and Probiotics; double-digit organic sales decline in UV filters • Aroma Molecules: High-single-digit organic sales growth and favorable comparables; double-digit organic sales growth in Menthol; mid-single-digit organic sales growth in Specialty Fragrance Ingredients 1,222 Q3 2025 Organic growth -6 Portfolio FX 1,310 Q3 2026 Q3 2025 Organic growth -5 Portfolio FX Q3 2026 -0.5% +2.3%+5.3% +7.2% +5.2% 0.0% +2.2% +7.4% +5.6% -1.1% +2.4% +6.9% 1) Selected customer contracts of the Terpene Ingredients business remain temporarily with Symrise Q3 2025 Organic growth 0 Portfolio FX Q3 2026
Page 6
— Q3 2026 Sales by Region Strong continued momentum in Asia Pacific and North America, Latin America emerging as an additional growth driver Organic sales growth by region 6 Asia Pacific +12.1%EAME +1.7% Latin America +7.4% North America +4.8% Note: see glossary on slide 28 for definitions. Sales by region % of global sales €1.310m Q3 NA LATAM EAME APAC 24% 14% 40% 22% Q3 2026 REVIEW
Page 7
— Q3 Execution Highlights 7 Continuing to drive growth while earning recognition for highest standards Chennai Digital & AI Hub Symvision AI Second hub after Barcelona opened in September: scaling data products, agentic AI process automation and global platform integration Expanded into an end-to-end innovation platform (Trend, Consumer, Concept, Design): from first market signal to final product, scalable beyond Food & Beverage TN&H The Magnum Ice Cream Company 2027+ Core strategic supplier status for innovation, technical expertise and sustainable vanilla sourcing Championing Chicken Investment in advanced technology at Berric expands capacity and flexibility, giving customers reliable access to a broad portfolio of chicken taste and nutritional solutions Scent & Care Lautier 1795, Grasse New Lautier 1795 site in Grasse expands premium natural fragrance capabilities. Together with Floral Concept, it connects local expertise, sourcing and production with Symrise’s global fragrance platform. L’Oréal Energy Award Symrise wins worldwide L’Oréal Energy Award for circular hydrogen recycling that advances decarbonization in cosmetics. Supports reliable supply and lower carbon intensity for everyday cosmetic applications Group
Page 8
8 02 Strategy & Transformation Update
Page 9
— PLANNED Executing Our ONE Symrise Strategy and ONE SYM Transformation 9 WHERE TO PLAY HOW TO WIN PURPOSE ENABLERS ONE SYM Transformation PORTFOLIO: Proactive Portfolio Management SUSTAINABILITY | DIGITALIZATION | PEOPLE AND VALUES INNOVATE IN HEALTH, WELLBEING AND BEAUTY, FOR THE ENTIRE FAMILY’S EVERYDAY LIFE EFFICIENCY: Leverage Global Scale GROWTH: Sharpen Value Creation ONE Symrise Strategy COMPLETED ACTIVE Phase 1: Design & Implement Phase 2: Activate & Start Delivering in a Structured Way Phase 3: Drive Momentum & Deliver Performance Harnessing and amplifying our potential to drive durable, profitable growth through our purpose-driven strategy Multi-year, organization-wide change program that supports implementation of our strategy and translates our ambitions into action April 2024 – Q1 2025 Commenced in Q2 2025 Future STRATEGY & TRANSFORMATION UPDATE
Page 10
ONE Symrise in Action: Portfolio Spotlight 10 Sharpening portfolio quality through disciplined capital allocation • Focus on higher-growth, innovation-led businesses with long-term strategic fit • Deliver higher quality earnings through improved margin profile and cash conversion • Maintain balance sheet strength • Redeploy capital into organic capacity and strategic acquisitions Portfolio INVEST Build Organically ↑ Capacity for growth and cost leadership Capacity Expansion Aroma Molecules Globalide® in India DIVEST Focus and Simplify Divestment Terpenes - Sharpens focus, improves quality of earnings ACQUIRE Strengthen and Grow + Accelerates leadership in premium Naturals Acquisition Floral Concept STRATEGY & TRANSFORMATION UPDATE Sept 2026 Closed Sept 2026 Closed Oct 2026 Ongoing
Page 11
— New Structure in Scent & Care A more focused organization, aligned with distinct business models and growth opportunities 11 STRATEGY & TRANSFORMATION UPDATE Portfolio What has changed • Established three focused business areas: Scent, Care & Wellness, and Aroma Specialties • Created Consumer Products and established Natural Ingredients as dedicated businesses within Scent • Combined Probiotics and Health Active Solutions under Health • Structured Aroma Specialties into Essential and Signature Ingredients Care & Wellness Scent Aroma Specialties Fine Fragrance Natural Ingredients Health • Probiotics • Health Active Solutions Micro Protection Advanced Actives Sun Functionals and Colors Essential Ingredients Signature Ingredients SCENT & CARE Consumer Products • Consumer Fragrance • Oral Care NEW NEW NEW NEW NEW NEW NEW
Page 12
— Aroma Specialties Essential Ingredients Signature Ingredients NEW NEW NEW Aroma Specialties: Focused Specialty Ingredient Platform 12 Sharpening our portfolio and enhancing operational efficiency to drive profitable growth STRATEGY & TRANSFORMATION UPDATE Portfolio Portfolio Efficiency Growth Where we play How we win… …Profitably S&C Focusing on specialty-driven, high-margin growth • Concentrating on attractive, higher-value segments • Exit non-strategic and commodity-oriented businesses • Build cost and scale leadership where we have a clear right-to-win • Leverage broad customer reach (>1,000 customers) • Scale high-impact specialty ingredients, including Globalide • Strengthen innovation pipeline • Enhance manufacturing efficiency and flexibility across global footprint • Reduce costs to reinforce leadership in Essential Ingredients • Leverage integrated production to support downstream profitability
Page 13
ONE SYM Transformation 13 Providing foundation for long-term profitable growth through strategic reinvestments Scale benefits: unlocks efficiency across global operations and procurement Digitalization: enables repeatability across the value chain STRATEGY & TRANSFORMATION UPDATE FUND INVESTMENT Advancing operational excellence to drive cost savings and efficiencies DRIVE EFFICIENCY Efficiency gains reinvested to drive profitable growth Commercial excellence: delivers faster, more consistent go-to-market execution Innovation: drives growth through high-impact, scalable solutions in key markets Enhancing competitiveness by strategically reinvesting cost savings in growth initiatives ACCELERATE GROWTH
Page 14
14 04 2026 Outlook
Page 15
— FY 2026 Outlook and Mid-Term Targets 2026 OUTLOOK 2026 Outlook Mid-term Targets (2025-2028) Organic Sales growth 2%-4% 5%-7% (CAGR) EBITDA margin 21.5%-22.5% (Adjusted) 21%-23% BFCF margin >14% (Adjusted) >14% Commentary • Q4 organic sales growth expected to moderate sequentially below the Q3 level against higher comparables • Underlying business momentum remains intact, with full-year organic sales growth expected near midpoint of guidance • Adjusted EBITDA margin expected in lower half of the guidance range, reflecting disciplined investments in IT, innovation and capabilities to support durable profitable growth • Multi-year growth opportunities ‒ Accelerated ONE SYM Transformation ‒ Structural growth tailwinds ‒ Emerging markets growth ‒ Product and technology innovation ‒ Portfolio opportunities 15
Page 16
— Our Continuing Commitment 16 Controlling the controllables while executing ONE Symrise Strategy and accelerating multi-year ONE SYM Transformation Enhance competitiveness through the acceleration of the transformation Drive durable, profitable growth across all our businesses Increase shareholder value through durable earnings expansion 1 2 3
Page 17
— Symrise AG 17 Financial calendar This document contains forward-looking statements, which are based on the current estimates and assumptions by the corporate man agement of Symrise AG. Future performance and the results actually achieved by Symrise AG and its affiliated companies depend on a number of risks and uncertainties and may therefore differ materially from the forward-looking statements. Many of these factors are outside Symrise’s control and cannot be accurately estimated in advance, such as the future economic environment and the actions of competitors and others involved in the marketplace. Symrise neither plans nor undertakes to update any forward-looking statements. Symrise AG Muehlenfeldstraße 1 37603 Holzminden, Germany René Weinberg Investor Relations rene.weinberg@symrise.com Contact 3 March 2027 Full Year Results 2026 28 April 2027 Trading Statement Q1 2027 29 July 2027 Interim Report January –June 2027 27 October 2027 Trading Statement Q3 2027
Page 18
Appendix 18
Page 19
— 9M 2026: Sales Performance 19 Market-leading OSG in Food & Beverage, strong performance in Fragrance Taste, Nutrition & Health in€m +3.9% -0.1% -1.2% +2.5% • Food & Beverage: BeveraMarket leading mid-single- digit organic sales growth, with high-single-digit organic sales growth in Naturals and Savory and low- single-digit organic sales growth in ges and Sweet • Pet Food: Low-single-digit organic sales growth, driven by Palatability; Pet Nutrition with continued price normalization • Organic sales growth of 3.0% in 9M 2026 • Portfolio effect from the disposal of the Aqua business, includes consolidation of Floral Concept and the divestment of Terpene Ingredients business¹ • FX headwinds continued to moderate • Fragrance: Mid-single-digit organic sales growth, driven by mid-single-digit organic sales growth in Consumer Fragrance; Fine Fragrance with low-single- digit organic sales decline • Care & Wellness: Below prior-year levels due to high comparables in UV filters; new divisional structure and differentiated portfolio support future growth • Aroma Molecules: Mid-single-digit organic sales growth, with high-single-digit organic sales growth in Specialty Fragrance Ingredients and mid-single-digit organic sales growth in Menthol Scent & Care in€m +1.8 % -0.3% -0.4 % +1.1 % Group in€m -0.2% -0.9%+3.0% +1.9% 88 2,263 -3 -28 2,320 1.513 1.530 28 -5 -6 115 3,776 -8 -33 3,850 9M 2026 REVIEW 9M 2025 Organic growth Portfolio FX 9M 2026 9M 2025 Organic growth Portfolio FX 9M 20269M 2025 Organic growth Portfolio FX 9M 2026 1) Selected customer contracts of the Terpene Ingredients business remain temporarily with Symrise
Page 20
— 9M 2026 Sales by Region Positive development in Asia Pacific and North America, Latin America as an additional growth driver Organic sales growth by region 20 Asia Pacific +9.1%EAME -1,3% Latin America +2,7% North America +5,3% Note: see glossary on slide 28 for definitions. Sales by region % of global sales NA LATAM EAME APAC 24% 14% 40% 22% 9M 2026 REVIEW €3.850m 9M
Page 21
— Glossary 21 APAC Asia Pacific BFCF Business Free Cash Flow DD Double digit EAME Europe, Africa, Middle East FX Foreign exchange HSD High single digit LATAM Latin America LSD Low single digit LTM Last twelve months MSD Mid single digit NA North America OSG Organic sales growth